Nimocard Infusion belongs to a group of medicines called calcium channel blockers indicated as prophylaxis and treatment of ischaemic neurological deficits caused by narrowing of blood vessels following subarachnoid haemorrhage of aneurysmal origin. Subarachnoid haemorrhage is the bleeding around the brain which is usually the result of bleeding from an aneurysm (a weakened area in a blood vessel).
 
Nimocard Infusion contains ‘Nimodipine’ that relaxes the smooth muscles of the small blood vessels in the brain, thereby allowing narrowed blood vessels to open up. This helps in increasing blood flow & circulation, reduces blood pressure, and lowers the risk of damage caused by insufficient blood flow to the brain after bleeding.
 
In some cases, Nimocard Infusion may cause side effects such as low blood pressure, vasodilation, nausea, constipation, flatulence, and diarrhoea. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if the side effects persist or worsen.
 
Consult your doctor if you are pregnant. Avoid breastfeeding while on treatment with Nimocard Infusion. Drive or operate machinery only if you are alert as Nimocard Infusion may cause dizziness. Nimocard Infusion is not recommended for children below 18 years as safety and effectiveness have not been established. Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects/interactions.

Nimocard Infusion is used in the prevention of brain damage due to subarachnoid haemorrhage. The detailed uses of Nimocard Infusion are as follows:

• Prevent brain damage after subarachnoid hemorrhage: Nimocard Infusion is primarily used to improve neurological outcomes in patients who have suffered a subarachnoid hemorrhage (bleeding around the brain) due to a ruptured aneurysm. It works by relaxing cerebral blood vessels and enhancing blood flow to affected brain regions.
• Reduce ischemic deficits in cerebral vasospasm: Nimocard Infusion helps prevent and treat cerebral vasospasm, a dangerous narrowing of blood vessels that often follows a brain hemorrhage. This effect decreases the likelihood of stroke-like symptoms and protects brain tissue from further injury.

• Nimocard Infusion is administered only by a healthcare professional, typically through a slow intravenous infusion.
• Dosage and duration are determined by the doctor based on the patient's condition and response to treatment.
• Do not self-administer this medication.
• Improper use can lead to serious side effects, including dangerously low blood pressure.
• Patients are closely monitored during treatment for vital signs and neurological status to ensure safety and effectiveness.

Nimocard Infusion belongs to the group of medicines called calcium channel blockers indicated as prophylaxis and treatment of ischaemic neurological deficits caused by cerebral vasospasm (narrowing of blood vessels) following aneurysmal subarachnoid haemorrhage. Nimocard Infusion contains ‘Nimodipine’ that relaxes the smooth muscles of the small blood vessels in the brain, thereby allowing narrowed blood vessels to open up. This helps in increasing blood flow & circulation, reduces blood pressure, and lowers the risk of damage caused by insufficient blood flow to the brain after bleeding.

Do not take Nimocard Infusion if you are allergic to any of its components. Inform your doctor if you have low blood pressure, fluid retention in the brain, bowel obstruction, epilepsy, alcoholism, heart kidney, or liver problems. Consult your doctor if you are pregnant. Avoid breastfeeding while on treatment with Nimocard Infusion. Drive or operate machinery only if you are alert as Nimocard Infusion may cause dizziness. Nimocard Infusion is not recommended for children below 18 years as safety and effectiveness have not been established.